Stay updated on Safety of SNA-120 in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Safety of SNA-120 in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of SNA-120 in Psoriasis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the completed Phase 2 SNA-120 study, including its eligibility criteria, locations, interventions, outcome measures, and study dates, instead of a 403 error page.
    Difference
    62%
    Check dated 2026-11-08T05:14:56.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.3%
    Check dated 2026-11-01T02:46:40.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website updates and says that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T03:10:36.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.1 to v3.7.2, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T02:41:47.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision indicator changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T02:56:40.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with basic site chrome, indicating access to the study record is blocked.
    Difference
    19%
    Check dated 2026-09-20T01:35:13.000Z thumbnail image

Stay in the know with updates to Safety of SNA-120 in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of SNA-120 in Psoriasis Clinical Trial page.